ResearcherFirst Affiliated Hospital of GuangXi Medical UniversityActive in the last 2 years
Jing Ning
Matched on ORCID iD 0000-0002-5289-331X; OpenAlex author ID A5006858509, A5100575886. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2023: 3 papers · 2024: 1 paper · 2025: none · 2026: 2 papers
Papers 6
- Oncostatin M promotes immune escape, invasion, and metastasis of pancreatic cancer by upregulating PD-L1 via the PI3K/AKT pathway. Co-author DOI 10.1016/j.ijbiomac.2026.152179↗
- IL-15 promotes immune escape, invasion, and metastasis of pancreatic cancer by upregulating PD-L1 expression via the JAK1/STAT1/IRF1 pathway. Co-author DOI 10.1186/s12964-026-02870-8↗
- Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway. Co-author DOI 10.1038/s41598-024-75089-7↗
- Identification of ZBTB4 as an immunological biomarker that can inhibit the proliferation and invasion of pancreatic cancer. Co-author DOI 10.1186/s12885-023-10749-x↗
- Local Sustained Chemotherapy of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Injection of Biodegradable Thermo-Sensitive Hydrogel. First author DOI 10.2147/ijn.s417445↗
- Erratum: Local Sustained Chemotherapy of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Injection of Biodegradable Thermo-Sensitive Hydrogel [Corrigendum… First author DOI 10.2147/ijn.s437867↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Haixing Jiang · 6 shared papers, 2023–2026 · strength 1.55
- Paper Oncostatin M promotes immune escape, invasion, and metastasis of pancreatic cancer by upregulating PD-L1 via the PI3K/A… DOI 10.1016/j.ijbiomac.2026.152179↗
- Paper IL-15 promotes immune escape, invasion, and metastasis of pancreatic cancer by upregulating PD-L1 expression via the JA… DOI 10.1186/s12964-026-02870-8↗
- Paper Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway. DOI 10.1038/s41598-024-75089-7↗
- Shanyu Qin · 4 shared papers, 2023–2024 · strength 0.88
- Paper Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway. DOI 10.1038/s41598-024-75089-7↗
- Paper Local Sustained Chemotherapy of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Injection of Biodegradable Thermo-… DOI 10.2147/ijn.s417445↗
- Paper Erratum: Local Sustained Chemotherapy of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Injection of Biodegradabl… DOI 10.2147/ijn.s437867↗
- Dan Yang · 3 shared papers, 2023–2024 · strength 0.72
- Paper Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway. DOI 10.1038/s41598-024-75089-7↗
- Paper Local Sustained Chemotherapy of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Injection of Biodegradable Thermo-… DOI 10.2147/ijn.s417445↗
- Paper Erratum: Local Sustained Chemotherapy of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Injection of Biodegradabl… DOI 10.2147/ijn.s437867↗
- Xiubing Chen · 2 shared papers, 2026 · strength 0.67
- Paper Oncostatin M promotes immune escape, invasion, and metastasis of pancreatic cancer by upregulating PD-L1 via the PI3K/A… DOI 10.1016/j.ijbiomac.2026.152179↗
- Paper IL-15 promotes immune escape, invasion, and metastasis of pancreatic cancer by upregulating PD-L1 expression via the JA… DOI 10.1186/s12964-026-02870-8↗
- Weiwei Zhang · 2 shared papers, 2026 · strength 0.67
- Paper Oncostatin M promotes immune escape, invasion, and metastasis of pancreatic cancer by upregulating PD-L1 via the PI3K/A… DOI 10.1016/j.ijbiomac.2026.152179↗
- Paper IL-15 promotes immune escape, invasion, and metastasis of pancreatic cancer by upregulating PD-L1 expression via the JA… DOI 10.1186/s12964-026-02870-8↗
- Xiubing Chen · 2 shared papers, 2023–2024 · strength 0.41
- Zhe Yang · 1 shared paper, 2023 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.